BRIEF-Sinocare to sell blood glucose monitoring products to Tecnosuma, sees 2014 profit up
Jan 23 (Reuters) - Sinocare Inc
* Says signs contracts to sell blood glucose monitoring products to Tecnosuma International for Cuba and Venezuela markets
* Says expects 2014 net profit to rise up to 30 percent y/y at 165.3-214.9 million yuan ($26.54-34.51 million)
Further company coverage: ($1 = 6.2279 Chinese yuan renminbi) (Reporting by Hong Kong and Singapore newsrooms)
© Thomson Reuters 2017 All rights reserved.